The mohs procedure for skin cancer offers the strongest odds of any available treatment. Still, strong odds are not a guarantee. A small number of patients see their cancer return, even after clean surgical margins. This article explains why recurrence happens and what steps protect your skin long after surgery ends.
Key Takeaways
- Mohs surgery removes cancer layer by layer and checks every margin under a microscope before you leave, which is why it outperforms standard excision for basal cell and squamous cell carcinomas.
- A 2.1% five-year recurrence rate sounds low, but certain tumor traits like perineural invasion and poor cell differentiation push that number higher for some patients.
- Because most recurrences show up within the first few years after surgery, what you do after treatment matters as much as the surgery itself.
- Mohs surgery gives you the best available starting point, but long-term skin health depends on staying in regular contact with your dermatologist.
- Common questions about how Mohs works, what recurrence looks like, and whether the procedure can be repeated are answered below.
How the Mohs Procedure Works, and Why Cure Rates Are So High
Mohs micrographic surgery achieves the lowest recurrence rates of any treatment for non-melanoma skin cancers. The reason is not the surgeon’s skill alone. It comes from the structure of the procedure itself.
Most skin cancer removal methods cut out the visible tumor plus a margin of surrounding tissue. That tissue then goes to an off-site lab, and you wait days for results. If margins are not clear, you return for more surgery. Mohs surgery skips that gap entirely.
The procedure starts with a local anesthetic applied to the treatment area. A dermatologic surgeon removes a thin layer of cancerous tissue and draws a surgical map of the sample. That map lets the lab team orient every piece of tissue. All edges, including the deep margin, get reviewed under a microscope.
If any margin still shows cancer, the surgeon removes only that area and repeats the process. This continues until the exam confirms clear margins on every side. Most cases finish in a single day, though some larger or more complex tumors need extra time.
Mohs surgery works especially well for tumors in cosmetically sensitive areas like the nose, eyelids, lips, and ears. It also suits aggressive tumor subtypes, tumors with unclear borders, and cancers that have already recurred once. The same specialist often reads the slides and performs the surgery. That means real-time answers instead of a separate lab report.
What happens after the cancer is removed?
Once the wound is clear, the focus shifts to closing it. The right option depends on the size and location of the defect.
Some wounds heal on their own through a process called secondary intention. Others need a skin flap, where nearby tissue is repositioned, or a skin graft, where tissue comes from another site. Larger or more complex defects sometimes call for reconstructive surgery. Reconstruction typically happens the same day, right after the final layer comes back clear.
According to StatPearls, Primary BCC (99%), recurrent BCC (94.4%), five-year cure rates reach 99% for primary basal cell carcinoma. Rates fall between 92% and 99% for primary squamous cell carcinoma. Tumors that have already recurred once show slightly lower cure rates. That gap is part of why early detection matters so much.
Standard excision and electrodessication estimate margins. Mohs surgery confirms them under direct microscopic view. That distinction drives most of the gap in outcomes between this procedure and other treatment options.
Why Skin Cancer Can Still Recur After Mohs Surgery
Even with confirmed clear margins, cancer recurrence after Mohs surgery is possible. The five-year recurrence rate stays low, but it is not zero.
A study published in the Journal of Investigative Dermatology tracked more than 1,100 patients and found a 2.1% (0.6, 3.5) after Mohs surgery recurrence figure. That rate is lower than what’s seen after standard excision or electrodessication. A separate study on periocular skin cancers found a similarly low recurrence rate over nearly four years of follow-up, even in one of the more anatomically difficult areas to treat.
So what causes recurrence when it does happen?
Tumor Characteristics That Increase Recurrence Risk
Several tumor traits raise the odds that cancer cells slip past even a careful surgical margin check. Understanding these traits helps explain why some patients need closer follow-up than others.
Poorly differentiated cells are a major risk factor. When tumor cells look very different from healthy tissue, they tend to grow faster and spread less predictably. That makes full clearance harder, even with careful margin checks.
Perineural invasion is another concern. This happens when cancer spreads along a nerve pathway. Residual cancer cells can travel beyond the visible surgical site through these pathways. That raises the recurrence risk for tumors with this feature.
Field cancerization adds a broader complication. Skin around a visible tumor may already carry DNA-level damage in the surrounding cells. That damage does not always show up under the microscope during surgery.
High-risk strains of human papillomavirus can also drive more aggressive squamous cell carcinoma behavior. Genetic mutations that affect how cells repair themselves can add to this risk.
Tumor location plays a role too. Cancers on the nose, ears, and eyelids sit closer to nerves and cartilage. That can make complete clearance more technically demanding. That doesn’t mean these areas carry worse outcomes, but it may mean your surgeon recommends closer monitoring afterward.
For patients whose cancer has spread to the lymph nodes, doctors may order more testing. Some cases call for sentinel lymph node biopsy, CT or PET scans, radiation therapy, targeted therapy, or photodynamic therapy. Not every dermatology practice offers all of these, and decisions about systemic treatment usually involve an oncology specialist.
Recurrence does not always look dramatic. It can appear as a small patch of persistent redness, a new bump, or a scar that won’t heal. Patients with a weakened immune system also face a higher baseline risk of recurrence, regardless of tumor type.
One real gap in the current research is the lack of a national registry tracking long-term recurrence after Mohs surgery. A clinical trial registered with ClinicalTrials.gov notes that recent data is lacking to validate this historical measurement. An ongoing study at Northwestern University aims to fill that gap by checking historical cure rates against more current outcomes.
Long-Term Skin Health: Sun Protection, Follow-Up Visits, and Skin Cancer Screening
The surgery may end, but the work continues. Most recurrences appear within the first few years after treatment, and that pattern shapes how dermatologists structure follow-up care.
The National Cancer Institute’s PDQ summary confirms that Most recurrences occur within 5 years. Consistent follow-up visits and sun protection give you the best chance of catching any returning cancer. Early detection means it has less time to grow.
Follow-up visits are where skin cancer detection actually happens. Your care team checks the surgical site and reviews your medical history. They also perform a full-body skin examination to look for new lesions. Regular check-ups, paired with lifelong skin exams as a habit, remain the main tools for catching problems early. Bring a list of any new or changing spots to each visit so nothing gets overlooked.
Sun protection is not optional after skin cancer treatment. Ultraviolet radiation causes ongoing damage to skin cells. UV exposure after surgery can trigger new tumors in skin that has already shown it is vulnerable. This risk does not fade quickly, so sun habits matter for years after treatment ends.
Protecting yourself from UV rays means a few consistent habits:
- Use broad-spectrum sunscreen with UVB/UVA coverage
- Wear protective clothing and a wide-brimmed hat
- Avoid tanning beds entirely
- Limit time outdoors during peak sun hours
Cutting back on sun exposure during these peak hours lowers your cumulative UV damage over time. Reapplying sunscreen every two hours outdoors makes a meaningful difference over a lifetime of sun exposure.
At home, the ABCDEF rule helps you monitor any skin lesion between appointments:
- Asymmetry, one half looks different from the other
- Border, edges appear ragged or blurred
- Color, uneven shading or multiple colors
- Diameter, larger than a pencil eraser
- Evolution, any change in size, shape, or color
Report anything that looks different from one week to the next rather than waiting for your next scheduled visit. A dermatologist can also show you how to perform a thorough self-check at home.
Post-operative care also means watching for signs and symptoms at the treatment site. New growth, color changes, or tenderness after the wound has healed are all worth mentioning to your care team. Your needs will likely shift over time, so your follow-up schedule should reflect your actual risk level. Most dermatologists recommend skin checks every six to twelve months for the first several years after treatment.
Family history also factors into how often you should be screened. If a parent or sibling has had skin cancer, mention that at your next visit. It helps your dermatologist tailor a more appropriate monitoring schedule. The CDC’s guidance to protect your skin from the sun pairs well with a skin cancer screening schedule that stays relevant for life, regardless of how clean your surgical margins were.
Will the mohs procedure for skin cancer keep you cancer-free?
The mohs procedure for skin cancer offers the highest documented cure rates for basal cell and squamous cell carcinomas. Those results hold up even in difficult anatomic locations. Recurrence is uncommon, but the biology behind it, from poorly differentiated cells to field cancerization, is worth taking seriously. Staying consistent with sun protection and follow-up visits gives you the best chance of catching anything early.
If you want to know where you stand personally, a board-certified dermatologist can walk you through your recurrence risk and build a follow-up plan around it. Schedule a skin cancer consultation with our team to get answers specific to your situation.
FAQs
What is the Mohs procedure for skin cancer?
Mohs surgery removes skin cancer one thin layer at a time, checking each layer under a microscope before removing the next. The process stops once no cancer remains at any margin. Doctors often use it for basal cell and squamous cell carcinoma on the face, scalp, and other sensitive areas.
How do I know if my skin cancer has come back after Mohs surgery?
A new growth, persistent redness, a sore that won’t close, or a firm area near the surgical site can signal recurrence. These signs may appear months or years later. See a dermatologist for any change near the treatment area instead of watching it at home.
How long after Mohs surgery should I watch for recurrence?
Most recurrences appear within the first two to three years after surgery, so that window calls for the most frequent follow-up visits. Your dermatologist will set a schedule based on your tumor type, location, and risk factors. Annual skin exams remain important even after the highest-risk window has passed.
Does skin cancer spread if it recurs after Mohs surgery?
Recurrent skin cancer can behave more aggressively than the original tumor. In some cases it may reach the lymph nodes or deeper tissue, especially if the original tumor had perineural invasion or poorly differentiated cells. Finding recurrence early through regular skin examination gives you more treatment options.
Can Mohs surgery be performed again if skin cancer returns?
Yes. You can repeat Mohs surgery at a previously treated site. Recurrent tumors carry higher risk, and repeat Mohs surgery still outperforms most other approaches. Your dermatologic surgeon will review the original treatment site and your full history before recommending next steps.
